Canadian cannabis producer Organigram Holdings said it is pausing production of its lozenge product in a 100-milligram THC package pending a resolution over an ongoing dispute with Health Canada.
The Toronto-headquartered company said it received a notification from Health Canada claiming the products were incorrectly classified and labeled as “extract” rather than “edible.”
ADVERTISEMENT
Organigram is one of a number of companies to have received such a notification this year.
In January, MJBizDaily reported that the federal cannabis regulator had begun asking some licensed marijuana companies to stop selling certain products the agency said were incorrectly classified and labeled as “extracts” rather than “edibles.”
From a packaging perspective, the distinction is important because any cannabis product classified as an “extract” has 100 times more allowable THC per package than a product considered an “edible,” making it more appealing to certain consumers.
Organigram launched the lozenge product
Read full article on Marijuana Business Daily
